Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 19366963.
- Also identified by DOI 10.2337/dc09-0275 and PMC identifier 2699705.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine whether serum uric acid predicts incident type 2 diabetes by glucose tolerance status in older community-dwelling adults. Participants without diabetes at baseline were evaluated for incident type 2 diabetes 13 years later. Baseline glucose tolerance status was defined as normoglycemia, impaired fasting glucose, and impaired postchallenge glucose tolerance. A total of 566 participants were included (mean age 63.3 +/- 8.6 years; 41% men). Regression models adjusted for age, sex, BMI, diuretic use, and estimated glomerular filtration rate showed that for each 1 mg/dl increment in uric acid levels, incident type 2 diabetes risk increased by approximately 60%. When analyses were stratified by glucose status, uric acid levels independently predicted incident type 2 diabetes among participants who had impaired fasting glucose (odds ratio 1.75, 95% CI 1.1-2.9, P = 0.02). Uric acid may be a useful predictor of type 2 diabetes in older adults with impaired fasting glucose.
Medical subject headings
- Biomarkers
- Diabetes Mellitus, Type 2
- Glucose Intolerance
- Uric Acid